Sa1646: GLP-1 AGONIST USE IS ASSOCIATED WITH OVERALL IMPROVEMENT OF SYMPTOMS IN PATIENTS WITH IBS-D AND OBESITY: A NATIONAL DATABASE ANALYSIS | Publicación